IL183877A0 - Stable particulate pharmaceutical composition of solifenacin or salt thereof - Google Patents
Stable particulate pharmaceutical composition of solifenacin or salt thereofInfo
- Publication number
- IL183877A0 IL183877A0 IL183877A IL18387707A IL183877A0 IL 183877 A0 IL183877 A0 IL 183877A0 IL 183877 A IL183877 A IL 183877A IL 18387707 A IL18387707 A IL 18387707A IL 183877 A0 IL183877 A0 IL 183877A0
- Authority
- IL
- Israel
- Prior art keywords
- solifenacin
- salt
- pharmaceutical composition
- particulate pharmaceutical
- stable particulate
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63838804P | 2004-12-27 | 2004-12-27 | |
JP2005085968 | 2005-03-24 | ||
PCT/JP2005/023771 WO2006070735A1 (ja) | 2004-12-27 | 2005-12-26 | ソリフェナシンまたはその塩の安定な粒子状医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL183877A0 true IL183877A0 (en) | 2007-10-31 |
Family
ID=40283425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL183877A IL183877A0 (en) | 2004-12-27 | 2007-06-12 | Stable particulate pharmaceutical composition of solifenacin or salt thereof |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP4636445B2 (cs) |
BG (1) | BG1677U1 (cs) |
BR (1) | BRPI0519270A2 (cs) |
CZ (1) | CZ23089U1 (cs) |
ES (1) | ES2387571T3 (cs) |
IL (1) | IL183877A0 (cs) |
MX (1) | MX2007007911A (cs) |
RU (1) | RU2397767C2 (cs) |
SK (1) | SK6196Y1 (cs) |
TW (1) | TW200635590A (cs) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140303254A1 (en) * | 2013-04-08 | 2014-10-09 | InnoPharma Licensing LLC | Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2005012I1 (no) * | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
US20060035923A1 (en) * | 2002-06-07 | 2006-02-16 | Rian Van Meeteren | Overactive bladder treating drug |
JP4523265B2 (ja) * | 2002-11-13 | 2010-08-11 | 旭化成ファーマ株式会社 | 排尿障害治療用口腔内崩壊製剤 |
-
2005
- 2005-12-26 JP JP2006550756A patent/JP4636445B2/ja not_active Expired - Fee Related
- 2005-12-26 BG BG1970U patent/BG1677U1/bg unknown
- 2005-12-26 BR BRPI0519270-6A patent/BRPI0519270A2/pt not_active IP Right Cessation
- 2005-12-26 SK SK5021-2011U patent/SK6196Y1/sk unknown
- 2005-12-26 ES ES05820232T patent/ES2387571T3/es active Active
- 2005-12-26 RU RU2007128815/15A patent/RU2397767C2/ru not_active IP Right Cessation
- 2005-12-26 MX MX2007007911A patent/MX2007007911A/es active IP Right Grant
- 2005-12-26 CZ CZ201124173U patent/CZ23089U1/cs not_active IP Right Cessation
- 2005-12-27 TW TW094146775A patent/TW200635590A/zh unknown
-
2007
- 2007-06-12 IL IL183877A patent/IL183877A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2397767C2 (ru) | 2010-08-27 |
RU2007128815A (ru) | 2009-02-10 |
BG1677U1 (bg) | 2013-04-30 |
TW200635590A (en) | 2006-10-16 |
JP4636445B2 (ja) | 2011-02-23 |
JPWO2006070735A1 (ja) | 2008-06-12 |
ES2387571T3 (es) | 2012-09-26 |
CZ23089U1 (cs) | 2011-12-19 |
BRPI0519270A2 (pt) | 2009-01-06 |
SK50212011U1 (sk) | 2012-01-04 |
SK6196Y1 (sk) | 2012-08-06 |
MX2007007911A (es) | 2007-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1832288A4 (en) | STABLE GRANULAR PHARMACEUTICAL COMPOSITION OF SOLIFENACIN OR ITS SALT | |
IL178249A0 (en) | Composition for solid pharmaceutical preparation of solifenacin or salt thereof | |
ZA200504239B (en) | Pharmaceutical suspension composition | |
IL191141A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL186665A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL187434A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL216734A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
IL178414A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
IL176749A0 (en) | ANTIBODIES TO MAdCAM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
IL194242A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL191623A0 (en) | Fused heterocyclic compounds and pharmaceutical compositions containing the same | |
IL188050A0 (en) | Azaindazole derivatives and pharmaceutical compositions containing the same | |
HK1090308A1 (en) | Directly compressible pharmaceutical composition for the oral admnistration of cci-779 | |
EP2078719A4 (en) | COMPOUND WITH BICYCLIC PYRIMIDINE STRUCTURE AND THE COMPOUND CONTAINING PHARMACEUTICAL COMPOSITION | |
ZA200704915B (en) | Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions | |
IL177496A0 (en) | Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
IL179253A (en) | The history of pyrimidine and its pharmaceutical preparations | |
EP1776112A4 (en) | HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS | |
EP1862183A4 (en) | PHARMACEUTICAL COMPOSITION WITH HEAVY WATER-SOLUBLE MEDICAMENT | |
IL180303A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
IL183930A0 (en) | Use of cladribine for preparation of pharmaceutical compositions | |
EP1852117A4 (en) | PHARMACEUTICAL AGENT COMPRISING SOLIFENACIN | |
IL179337A0 (en) | Pharmaceutical compositions for the treatment of pruritus | |
EP1767531A4 (en) | MEDICINAL COMPOSITIONS CONTAINING 6-HYDROXYBENZBROMARONE OR SALTS THEREOF | |
IL191680A0 (en) | Pharmaceutical compositions containing revaprazen or a salt thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NP | Permission for amending the patent specification granted (section 66, patents law 1967) | ||
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |